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Abstract. 
 
The type I keratin 17 (K17) shows a peculiar 
localization in human epithelial appendages including 
hair follicles, which undergo a growth cycle throughout 
adult life. Additionally K17 is induced, along with K6 
and K16, early after acute injury to human skin. To gain 
further insights into its potential function(s), we cloned 
the mouse K17 gene and investigated its expression 
during skin development. Synthesis of K17 protein first 
occurs in a subset of epithelial cells within the single-
layered, undifferentiated ectoderm of embryonic day 
10.5 mouse fetuses. In the ensuing 48 h, K17-expressing 
cells give rise to placodes, the precursors of ectoderm-
derived appendages (hair, glands, and tooth), and to 
periderm. During early development, there is a spatial 
correspondence in the distribution of K17 and that of 
lymphoid-enhancer factor (lef-1), a DNA-bending pro-
tein involved in inductive epithelial–mesenchymal in-
teractions. We demonstrate that ectopic lef-1 expres-
sion induces K17 protein in the skin of adult transgenic 
mice. The pattern of K17 gene expression during devel-
opment has direct implications for the morphogenesis 
of skin epithelia, and points to the existence of a molec-
ular relationship between development and wound re-
pair.
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I
 
N
 
 spite of a recent revolution in the discovery of novel
genes, the most reliable criterium to define the epithe-
lial nature of a cell remains keratin gene expression.
The pattern of keratin protein synthesis provides a useful
tool for studying progression through complex programs
of epithelial differentiation and cycles of epithelial self-
renewal (Moll et al., 1982; O’Guin et al., 1990; Byrne et al.,
1994). Keratins belong the superfamily of intermediate fil-
ament (IF)
 
1
 
 proteins. There are in excess of 35 keratin
genes, and these can be partitioned into two distinct se-
quence types, I and II, based their genomic structure and
nucleotide sequence homology (Fuchs and Weber, 1994).
Most keratin genes, including the type II K1–K8 and the
type I K9–K20, are expressed in soft epithelia (Moll et al.,
1982; O’Guin et al., 1990). In addition, a group of seven
type I (Ha1–Ha7) and six type II (Hb1–Hb6) keratin
genes are expressed in hard epithelia such as hair and nail
(Rogers et al., 1997; Winter et al., 1997). Epithelial cells
coordinately regulate the expression of at least one type I
and one type II gene, reflecting the requirement for both
types of keratin proteins in a 1:1 molar ratio to sustain the
assembly of 10-nm filaments (Coulombe, 1993). Many
type I and type II keratin genes are de facto regulated in a
pairwise fashion and in an epithelial tissue type- and dif-
ferentiation-specific manner, even though any combina-
tion of type I and type II proteins can produce a filamen-
tous polymer in vitro (Hatzfeld and Franke, 1985). The
notions of sequence diversity, pairwise regulation, and dif-
ferentiation-specific expression of keratin genes have
largely been conserved throughout evolution, suggesting
the existence of a functional link between keratin proteins
and the diversity of structure and function of epithelial tis-
sues.
Our laboratory is interested in the regulation and func-
tion of three keratin genes, the type II K6 and the type I
K16 and K17, which cannot be readily associated with
a well-defined epithelial context (O’Guin et al., 1990).
These genes show an analogous pattern of expression in
human skin that includes a constitutive expression in the
hair follicle, sporadic expression in the thick epidermis of
palm and sole skin, but no expression in interfollicular epi-
dermis (Moll et al., 1983; Troyanovsky et al., 1989). K17 is
also expressed in the myoepithelium surrounding secre-
tory epithelial cells in many glandular tissues (Troy-
anovsky et al., 1989). Moreover, K6, K16, and K17 are
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Abbreviations used in this paper
 
: e, embryonic day; IF, intermediate fila-
ment; K, keratin; ORS, outer root sheat; RT, reverse transcriptase.
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induced under conditions associated with enhanced prolif-
eration and abnormal differentiation, such as viral infec-
tion, inflammation, psoriasis, carcinoma, and after acute
injury to various stratified epithelia (Weiss et al., 1984;
Stoler et al., 1988; Jiang et al., 1994; Leigh et al., 1995; Pal-
adini et al., 1996; McGowan and Coulombe, 1998). Al-
though its functional significance has not yet been estab-
lished, the accumulation of K6, K16, and K17 occurs at the
expense of the keratins normally expressed under basal
conditions and correlates with major changes in epithelial
cytoarchitecture (Paladini et al., 1996; Coulombe, 1997;
McGowan and Coulombe, 1998).
In comparison with the other wound-induced keratins,
K6 and K16, relatively little is known about the signifi-
cance of K17 gene expression and the properties and func-
tion(s) of K17 protein. To gain some insight into this ques-
tion we wanted to examine K17 expression in a context
potentially related to wound repair, epidermal develop-
ment. Whereas one functional human 17 gene and two
pseudogenes have been characterized (Troyanovsky et al.,
1992), only a partial cDNA is available for mouse K17
(Knapp et al., 1987). To facilitate our studies we cloned the
full-length gene for mouse K17 and examined its expres-
sion by producing a high-titer monospecific antiserum. We
discovered that K17 is expressed at an early stage of skin
morphogenesis according to a complex spatial pattern, and
that the transcription lymphoid-enhancer factor (lef-1) is
likely to play a role in its regulation. Our data led us to pro-
pose a revised model for skin morphogenesis, and suggest
the existence of a molecular relationship between develop-
ment and the wound repair response in adult skin epithelia.
 
Materials and Methods
 
Materials
 
Materials were obtained from the following sources: 129SvJ mouse ge-
nomic library packaged into Lambda Fix II and pBluescript vector from
Stratagene (La Jolla, CA); restriction endonucleases and DNA modifying
enzymes from New England Biolabs (Beverly, MA); Superscript II re-
verse transcriptase from Life Technologies (Grand Island, NY); Nytran
membranes from Schleicher & Schuell (Keene, NH); Hybond-N filters
from Amersham Corp. (Arlington Heights, IL); phage and plasmid DNA
purification kits from QIAGEN Corp. (Santa Clarita, CA); LA-Taq DNA
polymerase from Panvera Corp. (Madison, WI); alkaline-phosphatase an-
tibody detection kit from Bio-Rad Laboratories (Hercules, CA). All other
chemicals were reagent grade and were typically obtained from Sigma
Chemical Co. (St. Louis, MO).
 
Animal Protocols
 
All studies involving animals were reviewed by the Johns Hopkins Uni-
versity Animal Use and Care Committee (Baltimore, MD). For studies in-
volving experimental injury adult mice were anesthetized with avertin and
their backs were epilated with Nair cream (Carter-Wallace Inc., New
York, NY). A surgical area was disinfected and full thickness skin wounds
were made with a 4-mm punch (AcuPunch; Acuderm Inc., Ft. Lauderdale,
FL). The injured area was cleaned and covered with anti-bacterial oint-
ment until the time of killing. For developmental studies, mouse embryos
were isolated from timed pregnancies of B6C3F1/J mice (Jackson Labora-
tory, Bar Harbor, ME). Individual matings were initiated at 6:00 pm and
monitored the next morning at 8:00 am. At this time the males were re-
moved and the females were examined for the appearance of a vaginal
plug. If copulatory plugs were detected, the date was recorded and the
pregnancy was timed using 12 noon as embryonic day (e) 
 
5 
 
0.5 d (Kauf-
man, 1992). On days 8, 9, 10, 12, 14, 16, and 18 at 12:00 noon, the embryos
were isolated and fixed in either Bouin’s fixative for subsequent embed-
ding in paraffin or frozen in OCT Compound (Tissue-Tek; Sakura
Finetek, Torrance, CA) for preparation of cryosections. Additional tis-
sues from lef-1 overexpressing and lef-1–null mice were obtained from E.
Fuchs (University of Chicago, Chicago, IL) (Zhou et al., 1995) and R.
Grosschedl (University of California, San Francisco, CA) (van Genderen
et al., 1994), respectively.
 
RNA Isolation
 
RNA samples were obtained from control and experimentally wounded
mouse back skin using guanidine thioisocyanate (GTC)-phenol extraction
method (Bessho et al., 1993). The wounded tissue samples were extracted
72 h after experimental injury to enhance the abundance of wound-induced
keratin gene mRNAs.
 
Immunological Analyses 
 
For immunoblot analyses, known quantities of recombinant human ker-
atins were electrophoresed, transferred to nitrocellulose, and the blots
were incubated with primary antisera diluted in blocking buffer (Tris-
buffered saline with 0.5% Tween 20 and 5% powdered milk). Bound
primary antibodies were revealed by alkaline phosphatase–conjugated
secondary antibodies as recommended by the manufacturer (Bio-Rad
Laboratories). The primary antisera for K17 and K6 were prepared as de-
scribed below. Immunohistochemical analyses were performed on 5-
 
m
 
m
sections prepared from either paraffin-embedded or fresh-frozen tissues.
The sections were first reacted with the primary antisera and then re-
vealed with either a peroxidase-based reaction (Kirkegaard and Perry
Laboratories, Gaithersburg, MD) or by indirect immunofluorescence
(Jackson Immunological Reagents, West Grove, PA). In addition to the
antisera mentioned above, other primary antisera used in these studies
were: a guinea pig anti-K8/18 purchased from ARP laboratories (Bel-
mont, MA); a mouse monoclonal anti-K10 (clone K8.60) from Sigma
Chemical Co.; a mouse monoclonal anti-K14 (LL001) donated by I. Leigh
(London Hospital Medical College, London, UK) (Purkis et al., 1990);
and a rabbit anti–lef-1 donated by R. Grosschedl (van Genderen et al.,
1994). Double-immunofluorescence staining using primary antibodies
from the same species (rabbit anti-K17 and rabbit anti–lef-1) was per-
formed as described (Lewis-Carl et al., 1993).
 
Screening the Mouse Genomic Library
 
Approximately 1.5 d 
 
3 
 
10
 
6 
 
phage clones were screened with [
 
a
 
-
 
32
 
P]dCTP
radiolabeled probes. The initial round of screening was performed using
two probes. The first probe was derived from the rod portion of the pub-
lished human keratin 16 cDNA (Paladini et al., 1995). This domain is
highly conserved among the type I keratin sequences, particularly K14,
K16, and K17. The second probe was generated by reverse transcription
(RT)-PCR using RNA isolated from mouse back skin 72 h after experi-
mental wounding as described (Takahashi et al., 1998). The oligonucle-
otides were based on the partial mouse K17 cDNA sequence published by
Knapp and colleagues (Knapp et al., 1987) and amplified a 700-bp frag-
ment containing the COOH terminus and 3
 
9 
 
untranslated regions of this
mRNA. The strategy was to use the first probe as a means of identifying
all the type I keratin genes contained in the library and then apply the
K17-specific probe on a duplicate set of filters to identify the K17 contain-
ing phages. Hybridization and washes were carried out as suggested by the
manufacturer (Stratagene). Positive colonies were isolated by repeated
plaque purification as described (Sambrook et al., 1989). Phage DNA was
extracted and analyzed by restriction enzyme digestion and Southern blot-
ting. DNA fragments expected to contain expressed regions of the K17
gene were subcloned in pBluescript KS
 
1
 
 and sequenced. DNA sequenc-
ing and reconstruction of mouse keratin 17 gene locus was performed with
the assistance of the Johns Hopkins University DNA Sequencing Core
Facility (Baltimore, MD).
 
Mouse K17 cDNA Clone
 
A cDNA clone containing the entire coding sequence of K17 was ob-
tained via RT-PCR with oligonucleotides derived from the SvJ129 ge-
nomic sequence using RNA from experimentally wounded back skin of a
SvJ129 mouse. The primers used were: forward primer, 5
 
9
 
-ACGTG-
GATCCCGCTGCCACCATGACCACCA-3
 
9
 
; and
 
 
 
reverse primer, 5
 
9
 
-
GCTGTAGCAGGAGGGTGATGCCGGAGCGGA-3
 
9
 
.
The PCR conditions applied were 94
 
8
 
C for 1 min (denaturation); 55
 
8
 
C
for 1 min (annealing), and 72
 
8
 
C for 2 min (elongation) for 25 cycles. The 
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1.3-kb product obtained (as expected) was subcloned in pGEM-T
(Promega Corp., Madison, WI) and subjected to DNA sequence analysis
as described above. Sense and anti-sense probes corresponding to the 3
 
9
 
-
untranslated region-specific probe were also generated and used by Car-
roll et al. (1997) for in situ analysis of K17 mRNA expression.
 
Antibody Production and Characterization
 
Synthetic peptides (see below) were conjugated to maleimide-activated
keyhole limpet hemocyanin carrier as described by the manufacturer
(Pierce Chemical Co., Rockford, IL) and used for the production of
monospecic anti-keratin polyclonal antisera in rabbits according to stan-
dard procedures (Covance Research Products, Denver, PA). A 12-mer
peptide, NH
 
2
 
-C-S-S-R-E-Q-V-H-Q-T-T-R-COOH, was used for the pro-
duction of an antiserum to K17 (anti-K17), and a 9-mer peptide, NH
 
2
 
-
C-S-S-T-I-K-Y-T-T-COOH, was used for the production of an antiserum
that recognizes all K6 isoforms (anti-K6gen; Takahashi et al., 1998).
Bleeds were tested with the immunoblot procedures described above us-
ing recombinant keratin proteins prepared as described (Takahashi et al.,
1994; Wawersik et al., 1997).
 
Results
 
Isolation and Characterization of Genomic and cDNA 
Clones for Mouse K17
 
We screened 10
 
6
 
 clones from a 129 SvJ mouse genomic li-
brary (average insert size: 15–20 kb). An initial pool of 31
phage clones was established in which two clones (desig-
nated 16-9 and 16-61) were found to hybridize strongly
with a K17-specific probe. Further analyses on these two
clones revealed that they contain overlapping inserts that
included the 3
 
9
 
 portion of a type I keratin gene whose cod-
ing and 3
 
9
 
 noncoding sequences were identical to the pre-
viously reported partial K17 cDNA (Knapp et al., 1987).
Genomic walking yielded a third phage, designated 16-8,
which contained the 5
 
9
 
 portion of this gene. DNA se-
quence analyses revealed the presence of a 925 nucleotide
overlap between the genomic inserts contained in phages
16-8 and 16-9. The contiguity of these two inserts in 129
SvJ mouse genomic DNA was confirmed by a PCR exper-
iment (data not shown).
The nucleotide sequence of all exons and intron–exon
junctions, 5
 
9
 
 upstream and 3
 
9 
 
noncoding sequences was de-
termined for the candidate K17 genomic clone (see Fig. 2).
The boundaries of the functional elements in the gene iso-
lated were established via comparison with the previously
cloned human K17 gene (Troyanovsky et al., 1992) and a
near full-length mouse K17 cDNA clone (see below). The
candidate mouse K17 gene contains eight exons inter-
rupted by seven introns (1–7). The sequence of the exon–
intron boundaries (Fig. 2) conforms to the consensus splic-
ing signals (Shapiro and Senapathy, 1987). All introns
occur within the protein coding sequence (Figs. 1 and 2) at
positions that are perfectly conserved in all type I keratin
genes, including human K17 (Troyanovsky et al., 1992).
Oligonucleotide primers spanning the putative transla-
tion start codon (forward) and 3
 
9
 
 non-translated region
(reverse) in the candidate K17 gene were used to obtain
an 
 
z
 
1.3-kb cDNA clone by RT-PCR. The nucleotide se-
quence of the cDNA clone is identical to the open reading
frame contained within exons 1–8 in the candidate K17 ge-
nomic sequence and to the previously reported mouse par-
tial K17 cDNA (data not shown) (Fig. 2). Together with
the distribution of the corresponding keratin protein ob-
served via immunohistochemistry (see below), this led us
to conclude that the gene and cDNA that we have isolated
encode mouse keratin 17.
An alignment of the cDNA and genomic sequences is
shown diagramatically in Fig. 1. As for other keratin genes
there is no obvious correspondence between the place-
ment of introns and the predicted protein domains. The 5
 
9
 
leader, the entire head domain and the 1A subdomain of
the rod are encoded by exon 1, the largest of the eight ex-
ons (Table I). Exons 2–6 code for nearly all the remaining
portions of the postulated 
 
a
 
-helical rod domain including
Figure 1. Relationship be-
tween genomic and protein
domain structure for mouse
K17. From the two overlap-
ping phage clones designated
16-8 and 16-9 shown in A, a
full-length type I keratin
gene was reconstructed as
shown in B. DNA sequencing
showed that this gene con-
tains an open reading frame
identical to that of a near full-
length (this study) and partial
(Knapp et al., 1987) cDNA
clones for mouse K17, and
highly related to a genomic
clone for human K17 (Troy-
anovsky et al., 1992). The
structure of the mouse K17
gene is identical to that of the
human orthologous gene and
all other type I keratin genes
(Troyanovsky et al., 1992), in that it contains eight exons (black boxes in B) and seven intervening introns comprised within z5 kilo-
bases of sequence. (C) K17 is predicted to show the tripartite domain structure common to all IF proteins with a nonhelical (HEAD) do-
main at the NH2 terminus, a central domain featuring extended regions of heptad repeats (1A, 1B, 2A, and 2B), and another nonhelical
(TAIL) domain at the COOH terminus. There is no obvious relationship beween the genomic and protein domain structures. 
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linkers, the exception being the last residue of subdomain
2B at the COOH terminus. The very short exon 7 codes
for this last residue and the first eight amino acids of the
nonhelical tail domain. Finally, the remainder of the tail
domain (31 amino acids) and the entire 3
 
9
 
 nontranslated
region are encoded by exon 8.
Inspection of the 5
 
9
 
 upstream sequence from our cloned
sequence revealed the presence of a TATAA motif lo-
cated 95 bases upstream of a potential translation start site
with the consensus sequence defined by Kozak (1987)
(Fig. 2). Inspection of the proximal 5
 
9
 
 upstream sequence
revealed the presence of consensus binding sites for sev-
eral known transcription factors (Fig. 2). These include
AP-2, which has been shown to concentrate at sites of fu-
ture hair follicle formation during epidermal development
(Byrne et al., 1994), and several NF-IL-6(C/EBP-
 
b
 
) and
GAS sites, which are involved in the upregulation gene ex-
pression during inflammation and viral infection as previ-
ously discussed for the human K17 gene (Proby et al.,
1993; Jiang et al., 1994; Troyanovsky and Leube, 1994;
Bonnekoh et al., 1995; Vogel et al., 1995; Komine et al.,
1996). A detailed analysis of the complete K17 promoter
sequence will be reported elsewhere.
 
The Human and Mouse K17 Gene and Predicted 
Protein Sequences Are Highly Conserved
 
Table I compares various functional elements from the
mouse (this study) and human K17 gene (Troyanovsky et
al., 1992). At 
 
z
 
4.8 kb in total length, the mouse gene is
slightly shorter than its human orthologue, due primarily
to shorter introns 1 and 2. Whereas exon 8 is shorter in
mouse at the level of the 3
 
9 
 
noncoding portion, exons 1–7
are of identical size between mouse and human (Table I).
As a result, the K17 protein is predicted to be of similar
size in human and mouse (see below). As illustrated in Fig.
1, the mouse K17 gene is flanked by a K17-like gene on its
5
 
9
 
 side and the K16 gene on the 3
 
9 
 
side. A characterization
of the latter will be reported elsewhere (McGowan, K.M.,
K.M. Hess, and P.A. Coulombe, manuscript in prepara-
tion). Of note, Troyanovsky et al. (1992) showed that the
functional human K17 gene is flanked by a K17 pseudo-
Figure 2. Nucleotide sequence of exons and
flanking regions for the mouse K17 gene. Se-
quences corresponding to protein coding strand
for exons 1–8 are shown in uppercase letter, and
the predicted amino acid encoded (one-letter
code) is indicated directly above. Amino acids
are numbered at right starting with the initial
methionine. The 59 boundary of exon 1 has not
been determined. Sequences corresponding to
intron boundaries are shown as lowercase letters.
In the 59 upstream sequence, the canonical
TATA sequence (295 bp from the ATG transla-
tion start) is underlined, as are potential binding
sites for known transcription factors (Boulikas,
1994). In the 39 sequence, the canonical polyA
signal sequence (AATAAA) is underlined. This
sequence can be accessed at GenBank (Gen-
Bank/EMBL/DDBJ accession number applied
for). 
McGowan and Coulombe 
 
K17 Expression during Skin Morphogenesis
 
473
 
gene on its 5
 
9
 
 side and the functional K16 gene on its 3
 
9
 
side, all of which reside within the cluster of type I keratin
genes on chromosome 17q. It appears likely that these ker-
atin genes reside on chromosome 11q in mouse, since it is
syntenic with human chromosome 17q and contains a clus-
ter of type I genes (Nadeau et al., 1989).
An alignment of the predicted amino acid sequences of
mouse and human K17, as well as human K14 and K16, is
shown on Fig. 3. The mouse sequence (433 amino acids) is
longer than human K17 by one amino acid (Table I) due
to the insertion of a Pro residue at position 400 within the
tail domain (Fig. 3). The primary sequence of the head,
rod, and tail domains of mouse and human K17 show 88%
(73 out of 83 residues), 96% (302 of 312 residues), and
97% identity (37 of 38 residues), respectively. Most of the
amino acid substitutions between mouse and human K17
are conservative in nature, and four of them render mouse
K17 identical to human K14 (see residues marked by # in
Fig. 4). This exceptionally high degree of sequence relat-
edness between mouse and human K17 suggests, when in-
terpreted in light of their highly conserved regulation (see
below), that a K17 ancestral gene was present before the
divergence of these species during evolution, and that the
function(s) of the protein is conserved.
As pointed out for the human sequences (Troyanovsky
et al., 1992), mouse K17 is more related to K14 (73% iden-
tity) than to K16 (66% identity), due primarily to a better
conservation of the tail domains in K17 and K14 (Fig. 3).
In addition, the central rod domain of mouse K17 is more
related to that of human K14 (88% identity) than to hu-
man K16 (81% identity). We recently showed that unlike
K16, human K14 and K17 are capable of forming very sta-
ble heterotetramers with a variety of type II keratin part-
ners, including K5, K6, and K8 (Wawersik et al., 1997).
 
Expression of K17 in Intact and Wounded Adult Mouse 
Trunk Skin
 
The commercially available antiserum against K17 (mono-
clonal; Sigma Chemical Co.) has a low titer and does
not react with mouse K17 (our unpublished data). This
prompted us to produce a polyclonal antiserum in rabbits
using a hapten-conjugated 11-mer peptide that is perfectly
conserved at the COOH terminus of human and mouse
K17, and which is distinct from the related K14 sequence
(Fig. 3). When used for Western blotting at a high dilution
(1:10,000), the rabbit antiserum does not react with K14
and K16, but reacts strongly with purified recombinant hu-
man K17 (Fig. 4 
 
A
 
). In total insoluble proteins extracted
from mouse trunk skin, the rabbit antiserum recognizes a
single antigen with an apparent 
 
M
 
r
 
 of 48 kD (Fig. 4 
 
B
 
)
which comigrates with human K17 under standard gel
buffer conditions (Fig. 4). This reactivity is not seen with
the preimmune serum from the same rabbit, and can be
successfully competed out with the free peptide used in
the production of the antiserum (data not shown). These
data establish that we produced a high-titer antiserum that
is monospecific for K17, and confirms that the mouse and
human K17 proteins do not differ significantly in their ap-
parent 
 
M
 
r
 
 by conventional gel electrophoresis.
When applied on sections of adult mouse trunk skin
(Fig. 5), the K17 antiserum reacts strongly with hair folli-
cles (Fig. 5, 
 
A
 
 and 
 
B
 
) and sweat glands (data not shown),
but not with normal interfollicular epidermis. In hair folli-
cles, the entire outer root sheat (ORS) is immunostained,
whether the follicle is actively growing (anagen phase; Fig.
5, 
 
A
 
 and 
 
B
 
) or resting (data not shown). Most, if not all,
ORS keratinocytes are positively stained for K17, unlike
K6, whose protein distribution is restricted to the inner-
most ORS layers (Fig. 5, compare panels 
 
C
 
, 
 
D
 
, and 
 
E
 
). Al-
though the difference in K6 and K17 distribution is best
seen in the context of larger hair follicles, such as those
presented in Fig. 5, it applies for all hair types (see Fig. 11,
showing longitudinally sectioned pelage hair). Similar
findings were obtained in human skin samples (data not
shown).
Close examination of the hair bulb area revealed the
consistent presence of faint immunostaining for K17 in the
matrix cells and stronger staining in the early differentiat-
ing hair epithelial cells (trichocytes) (Fig. 5, 
 
F
 
–
 
H
 
). The sig-
nal is lost in the upper segments of the hair (data not
shown), owing probably to epitope masking. Such immu-
nostaining for K17 occurs in all types of hair follicles, and its
specificity is supported by control experiments involving
the use of preimmune serum or the addition of the peptide
immunogen to the anti-K17 serum (data not shown). Re-
examination of in situ hybridization data (Carroll et al.,
1997), which made use of a probe corresponding to the 3
 
9
 
portion of the K17 mRNA, revealed the presence of K17
transcripts in the early differentiating trichocytes of vibris-
sae (Fig. 5 
 
I
 
) and pelage hair follicles (data not shown). A
similar outcome was observed in a previous report by Pan-
teleyev et al. (1997), but these authors attributed their re-
sults to the presence of melanin granules. We have ob-
 
Table I. Comparing the Mouse and Human K17 Genes
 
Mouse K17 Human K17
 
Total length of the gene 4,852 bp 5,146 bp
Length of coding sequence 433 aa 432 aa
Size of exons/introns (in base pairs)
Exon 1 432 432
Intron 1 756 1,045
Exon 2 83 83
Intron 2 365 438
Exon 3 157 157
Intron 3 612 600
Exon 4 162 162
Intron 4 538 501
Exon 5 126 126
Intron 5 89 86
Exon 6 221 221
Intron 6 87 100
Exon 7 26 23
Intron 7 823 847
Exon 8 278 291
Predicted protein size 48,159 D 48,103 D
Observed protein size (SDS-PAGE)
 
z
 
48 kD
 
z
 
48 kD
Chromosomal mapping 11 17q12-q21
Identity of upstream gene K17-like K17 pseudogene
Distance to upstream gene 2 kb 2 kb
Downstream gene K16 K16
Distance to downstream gene — 5.0 kb 
The Journal of Cell Biology, Volume 143, 1998 474
 
served this same pattern of immunostaining using samples
obtained from unpigmented mice. Furthermore, immu-
noreactivity for K17 can be observed in Western blots
analysis of protein extracts prepared from mouse hair clip-
pings (the lack of K14 in such extracts confirms the ab-
sence of ORS contamination; data not shown). Finally, we
can detect reporter transgene activity in trichocytes in the
context of studies involving the 5
 
9
 
 upstream sequence of
the mouse K17 gene (McGowan, K.M., and P.A. Cou-
lombe, unpublished observations). Our ability to detect
K17 protein in trichocytes, an occurrence that has never
been reported before, may be primarily the result of the
high titer and specificity displayed by our polyclonal anti-
serum.
We previously showed, using the commercially available
monoclonal antibody (Sigma Chemical Co.), that K17 is
induced at the wound edge starting 12 h after acute injury
to human epidermis (Paladini et al., 1996). Likewise,
Knapp et al. (1987) showed that a mouse type I keratin
mRNA, which later on was identified as K17 (see Troy-
anovsky et al., 1992; Schweizer, 1993), is induced in skin
wounds. Application of our novel antiserum to sections of
adult mouse wounded skin showed that K17 is already in-
duced by 8 h after acute injury (Fig. 5, 
 
E
 
 and
 
 F
 
). In older
wounds, K17 synthesis extends distally from the cut edge
of the wound and is particularly strong in the migrating
epidermal tissue, where it occurs in all epidermal layers
(Fig. 5, 
 
G
 
 and 
 
H
 
; 48 h after injury). The epidermal staining
for K17 eventually disappears after wound closure (data
not shown). These data establish that, as was found to be
the case for K6 and K16 in human skin (Paladini et al.,
1996), K17 is an early marker of the process of kerati-
nocyte activation after injury and is expressed in the mi-
grating epithelium.
 
Onset of K17 Expression Occurs Early in Developing 
Mouse Skin
 
Until 
 
z
 
e9.5 d, the single-layered ectoderm covering the
surface of the embryo expresses the keratins 8 and 18 typi-
cal of simple epithelia (Jackson et al., 1981). The earliest
molecular indices of epidermal gene expression, starting at
 
z
 
e9.5 d, occur in the form of the transcription factor AP2
and its target genes K5 and K14. Byrne et al. (1994)
Figure 3. Alignment of the predicted amino acid
sequences for mouse K17 (this study) and human
K17 (Troyanovsky et al., 1992), K14 (Marchuk et
al., 1984), and K16 (Paladini et al., 1995). This
alignment was produced using the DNASIS v.3.5
software (Hitachi Software Engineering Inc., To-
kyo, Japan), using default parameters. The
boundaries of the major domains shared by all IF
proteins (Fuchs and Weber, 1994) are indicated
with brackets: a nonhelical head domain at the
NH2 terminus; the a-helical subdomains 1A, 1B,
2A, and 2B characteristic of the central rod do-
main; and the nonhelical tail domain at the
COOH terminus. Asterisks, nonsense stop
codons. Underneath the aligned sequences, the
symbols 1 and # identify residues that are differ-
ent between mouse and human K17; #, the sub-
set for which mouse K17 is identical to either
K14 or K16; ^, residues that are conserved be-
tween mouse and human K17 but different in
both K14 and K16. 
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showed that onset of expression of these genes takes place
according to a complex spatiotemporal pattern that does
not correlate with the initial stratification of the ectoderm.
In agreement with previous reports (Jackson et al., 1981;
Thorey et al., 1993), we find that e9.5-d ectoderm stains
uniformly with an antiserum directed against K8/K18 but
sporadically with antisera directed against K14 (data not
shown). At e10.5 d, expression of K14 has generalized to a
significant portion of the surface ectoderm. These data es-
tablish the validity of our antibody tools. We performed
triple-staining studies that include the DNA stain Hoechst
to analyze the context in which K17 expression is initiated
in the early stages of skin morphogenesis. These studies
made use of saggital sections of whole e12.5-d embryos, as
these feature areas with single layered ectoderm (e.g., up-
per dorsum), two-layered ectoderm (e.g., lower dorsum),
and stratified epithelium (e.g., ventral surface).
We find that induction of K17 expression takes place in
cells that express both K8–K18 and K14. The induction is
independent of stratification of the epithelium, as it is seen
in single-layered ectoderm (Fig. 6, 
 
A
 
–F), in the bottom
layer of two-layered epithelium (Fig. 6, G and H), in the
top layer of the stratified epithelium on the ventral surface
of the embryo (Fig. 6, I and J). In favorable sections, the
filamentous nature of the K17 staining can clearly be seen
at higher magnification (Fig. 6 K). As previously reported
(Greer and Roop, 1991; Byrne et al., 1994), no expression
of K10 can be detected in sections prepared from e12.5-d
embryos (data not shown). These data establish that K17
protein synthesis occurs shortly after the onset of K14 ex-
pression, before the onset of epithelial differentiation-spe-
cific gene expression.
Onset of K17 Expression Reflects the Adoption of a 
Nonepidermal Cell Fate in Embryonic Skin
As mentioned above, we observe very patchy expression
of the K17 gene in the ectoderm of the upper dorsum re-
gion of e10.5-d embryos (Fig. 7 A). Examination of sec-
tions prepared from several embryos suggest a periodicity
in the distribution of K17, in that clusters of one to three
positively stained cells occur at regularly spaced intervals
along the dorsal surface of the embryo. This staining pat-
tern is more firmly established at e12.5 d (Fig. 7 B). Be-
tween e12.5 and e14.5 d, the two-layer ectoderm further
stratifies to give rise to embryonic epidermis over most of
the embryo surface, whereas the first signs of hair follicle
induction occur in the form of an invagination of small
groups of epithelial cells into the underlying mesenchyme.
We find that the placodes and the proximal epithelial tis-
sue are both strongly immunostained for K17 (Fig. 7, C, D,
and E show various stages of placode formation in e14.5-d
epidermis). Continued downward expansion of the pla-
codes gives rise to primary hair germs, starting at e14.5 d
and well established by e16.5 d (Mann, 1962; Hardy and
Vielkind, 1996). The strong expression of K17 persists in
the primary hair germs at e14.5 d (Fig. 7 F) and e16.5 d
(Fig. 7 G), and examination of sections from several em-
bryos shows that the majority of the epithelial cells in pri-
mary hair germs are K17 positive. Collectively, our data
suggest that the precursors of pelage and vibrissae hair fol-
licles arise from small clusters of K17–positive ectoderm
that first appear in the undifferentiated ectoderm of e10.5
and e12.5 mouse embryos.
Another ectodermal cell type that is uniformly and con-
sistently immunopositive when stained with anti-K17 is
the periderm. As is the case of K6 (see below), the peri-
derm staining begins at e14.5 d (Fig. 7, C–F) and extends
(Fig. 7 G, e16.5-d sample) until this layer is lost from the
surface of the embryos shortly before birth (Fisher, 1994).
The embryonic epidermis is mostly negative for K17,
with the exception of a transient expression in the basal
layer starting at e14.5 (Fig. 7 F) and peaking at e16.5 d
(Fig. 7 G). This finding is rather intriguing, as differentia-
tion specific gene expression is already ongoing in the em-
bryonic epidermis during this period (data not shown)
(Dale et al., 1985; Greer and Roop, 1991; Byrne et al.,
1994). This expression has already begun to recede to-
wards developing hair follicles by e18.5 d and is further re-
stricted to the neck of hair follicles openings in dorsal
trunk skin of newborn mice (Fig. 7 H).
K17 Expression Is Partially Uncoupled from That of
K6 in Embryonic Skin
We examined the expression of K6 in our collection of em-
bryo specimens using a newly produced rabbit polyclonal
antiserum (refer to Materials and Methods). This type II
keratin is coregulated with K17 in wound edge epidermis
after injury to human and mouse adult skin (Paladini et al.,
1996; Takahashi et al., 1997, 1998), and is presumed to be
the type II pairing partner for K17 in several stratified epi-
thelia (e.g., O’Guin et al., 1990). In e12.5-d embryos, a
Figure 4. Validation of the specificity of a rabbit antiserum raised
against a conjugated 12-mer peptide corresponding to the COOH
terminus of mouse and human K17. (A) 50 ng of FPLC-purified
human recombinant K14 (lane 1), K16 (lane 2), and K17 (lane 3)
were prepared as described (Wawersik et al., 1997), electro-
phoresed in triplicate, and transferred on nitrocellulose mem-
branes. These were reacted with the monoclonal antibody LL001
directed against K14 (Purkis et al., 1990), a rabbit polyclonal anti-
serum directed against K16 (Takahashi et al., 1994), and the
newly produced antiserum against K17 (this study). (B) Immuno-
blot analysis of electrophoresed total skin proteins (20 mg) pre-
pared from the back of an adult mouse (lane 2). A single band
comigrating with purified human recombinant K17 (25 ng; lane
1), with an apparent Mr of 48 kD, reacts with the polyclonal anti-
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Figure 5. Immunolocalization of K17 protein in sections prepared from adult mouse skin. Tissues were fixed, paraffin embedded, and
5-mm sections were processed for hematoxylin-eosin staining, for K17 of K6 immunohistochemistry using a peroxidase-based detection
method, or for in situ hybridization as described (Carroll et al., 1997). A (K17 stain) and B (H & E), consecutive cross sections of intact
trunk skin showing anagen phase hair follicles (HF). C (K17 stain), D (H & E), and E (K6 stain) represent consecutive cross sections of
adult tail skin where on can observe profiles of hair follicles at two different levels. In contrast to K6, K17 immunostaining occurs in
both levels, indicating a more extensive distribution along the longitudinal axis of the follicle. Furthermore, K17 staining is present in all
the ORS layers whereas K6 is polarized to the innermost layers, as indicated by the opposing arrowheads in C, D, and E. Finally, the ar-
rows in these frames point to the occurrence of K17 staining in the hair shaft in the lower segment of the follicle. F (K17 stain), G (H &
E), and H (K17 stain) document the occurrence of K17 immunoreactivity in the matrix epithelial cells (M) and early differentiating tri-
chocytes (arrows). This staining is clearly distinct from that specific to the ORS compartment. (I) Localization of K17 mRNA by in situ
hybridization using a 39 noncoding probe. In this large vibrissae follicle, a strong hybridization occurs for both the hair matrix (M) and
hair epithelial cells as well as the ORS. J (K17 stain), K, L (H & E), and M (K17 stain) illustrate the induction of K17 immunoreactivity
in wound edge epidermis at 8 h (J and K) and 48 h (L and M) after injury. W, wound site. Bars: (A and B) 100 mm; (C–I) 100 mm; (J–M)
100 mm.McGowan and Coulombe K17 Expression during Skin Morphogenesis 477
strong staining for K6 protein occurs in the oral mucosa
whereas the surface ectoderm is negative (data not shown).
In e14.5-d embryos, K6 immunoreactivity occurs the in-
nermost aspect of the developing vibrissae follicles (Fig. 8
A) and in the periderm layer, which is uniformly stained
(Fig. 8, A and B). Similarly to K17, the periderm staining
for K6 persists (Fig. 8 C) until the loss of this layer before
birth (data not shown). In contrast to K17, however, we
detect K6 immunoreactivity at a relatively late stage of
pelage hair follicle development (e16.5 d), where it is re-
stricted to a subset of epithelial cells (Fig. 8 C). This pat-
tern is maintained in e18.5-d embryos and newborn mouse
skin (data not shown). Consistent with previous reports
situating the onset of hair-specific keratin gene expression
at e14.5–e15.5 d (Zhou et al., 1995), onset of K6 expression
appears to coincide with the beginning of differentiation in
developing hair follicles. These data establish that with the
notable exception of the entire periderm and a small sub-
set of hair epithelial cells (see Discussion), K17 expression
is largely uncoupled from that of K6 in developing skin.
Expression of K17 Coincides with That of the 
Transcription Factor lef-1 during Skin Development
The epithelial placodes that serve as precursors of hair fol-
licles and other appendages form directly above conden-
sates of specialized mesenchymal cells with inductive
properties (Sakakura et al., 1976; Kollar et al., 1983;
Hardy, 1992; Jowett et al., 1993). Lef-1, a protein that be-
longs to the HMG box family of transcription factors
(Clevers and Grosscheld, 1996), is known to play a critical
role in the epithelial–mesenchymal interactions that un-
derlie appendageal morphogenesis. Lef-1 is expressed in
the cell condensates that form at sites of future hair follicle
formation (e.g., Zhou et al., 1995; Kratochwil, 1996), and
mice harboring a null mutation in their lef-1 gene show a
significantly reduced number of hair follicles, a failure to
form teeth and mammary glands, and die shortly after
birth (van Genderen et al., 1994). Given this, we decided
to relate the expression of K17 to that of lef-1 in our col-
lection of mouse embryo sections.
Figure 6. Distribution of K17
protein an early stage of
mouse skin development.
Triple-immunofluorescence
staining was performed on
sections prepared from fresh-
frozen e12.5-d mouse em-
bryos to assess the context in
which K17 expression first
occurs in the embryonic ecto-
derm. (A–C) Portion of the
upper dorsum showing sin-
gle-layer ectoderm as deter-
mined by the vital Hoechst
stain for DNA (C). A single
cell is seen to express K17
(arrowhead in A), whereas
K14 expression is uniformly
established at that stage (B).
(D–F) Another example of
single-layer ectoderm (Hoechst
stain in F). Two adjacent cells
are seen to express K17 (ar-
rowhead in D), whereas uni-
form K8–K18 expression is
maintained at that stage (E).
(G and H) Portion of the
lower dorsum showing two-
layered ectoderm. In this ex-
ample, K17 induction occurs
in the bottom layer of the
ectoderm (arrowhead in G),
which is otherwise uniformly
stained for K14 (H). (J and
K) Portion of the ventral sur-
face showing three-layered ec-
toderm. In this case, K17 in-
duction occurs in the top layer
of the ectoderm (arrowhead
in  I), whereas again the stain-
ing for K14 is uniform (J). (K) At higher magnification, the filamentous nature of the anti-K17 staining is readily apparent in individual
epithelial cells. In all panels, the arrow depicts the interface between the surface epithelium and the underlying mesenchyme. Bars: (A–J)
20 mm; (K) 10 mm.The Journal of Cell Biology, Volume 143, 1998 478
Immunostainings for lef-1 performed on frozen sections
prepared from e12.5-, e14.5-, and e16.5-d mouse embryos
confirmed the elegant whole mount in situ hybridization
findings reported by Zhou et al. (1995). The lef-1 protein
staining is predominantly nuclear, as expected for a tran-
scription factor, and is initially manifested in and around
epithelial placodes (Fig. 9, A and B; e14.5-d embryo dor-
sum). The presence of lef-1 in both the epithelial cells
forming the placode and in proximal mesenchymal cells is
consistent with its role in epithelial–mesenchymal interac-
tions (Kratochwil et al., 1996). These sites of epithelial–
mesenchymal interactions, as identified by lef-1 protein
stainings, also display a strong signal for K17 (Fig. 9, A and
B). A survey of samples obtained from dual-staining ex-
periments of e14.5-d embryos show that the spatial corre-
spondence between the signals for K17 and lef-1 proteins
is striking. This is well illustrated in the context of double-
staining experiments (hair placode shown in Fig. 9, C and
D) and staining of consecutive frozen sections (vibrissae
shown in Fig. 9, E and F). As hair placodes evolve into pri-
mary hair germs, e.g., in e16.5-d embryos, the spatial cor-
respondence between the two signals persists only at the
tip region near the mesenchyme (data not shown). In addi-
tion, the basal layer of e16.5-d interfollicular epidermis is
clearly positive for both K17 and lef-1 proteins (Fig. 9, B
and C). In contrast to K17, however, we could not detect a
convincing signal for lef-1 in the periderm layer at any
Figure 7. Distribution of K17
protein during skin develop-
ment. Sections were prepared
from fresh-frozen e10.5-,
e12.5-, e14.5-, and e16.5-d
mouse embryos and from
newborn mice and immu-
nostained for K17 using a
peroxidase-based detection
method. Examples were cho-
sen so as to represent the
continuum of events charac-
terizing skin morphogenesis.
K17 is first induced in the sin-
gle layer ectoderm in e10.5-d
embryos (arrowheads in A).
At e12.5 d, small clusters of
K17-positive cells occur at
periodic intervals in the cross
sectioned ectoderm (arrow-
heads in B). These clusters
subsequently evolve into pla-
codes and then primary hair
germs, as suggested by the
pattern of K17-staining in
frames C–G ( open arrow-
heads). At e14.5 d, the peri-
derm (p) is also distinctly
stained for K17 (C–E). More-
over, beginning at e14.5 d (F) and firmly established by e16.5 d (bracket in G), the basal layer of embryonic epidermis expresses K17.
Between e16.5 d and birth (H), the staining for K17 in the basal layer as well as the periderm is gradually lost. At birth, the skin features
an adult pattern of K17 expression, in that the latter is largely restricted to the hair follicles. In all frames, the small arrow depicts the
interface beween the surface epithelium and the underlying mesenchyme. See text for further explanation. Bars: (A–G) 50 mm; (H)
82 mm.
Figure 8. Distribution of K6 isoform proteins during skin devel-
opment. Sections were prepared from fresh-frozen mouse em-
bryos and immunostained for K6 protein using a peroxidase-
based detection method. K6 staining is first detected in e14.5-d
embryos, where it is restricted to a subset of cells within the
vibrissae (vib in A) and the periderm (p; shown are whisker pads
in A and trunk skin in B). At e16.5 d, K6 staining is detected in a
small subset of epithelial cells within primary hair germs (arrows
in C), coinciding with the onset of differentiation-specific gene
expression (see text). Solid arrowhead, interface between the sur-
face epithelium and the underlying mesenchyme. Bar, 100 mm.McGowan and Coulombe K17 Expression during Skin Morphogenesis 479
stage of its formation. In newborn skin, the signal for lef-1
is mostly restricted to the actively growing (bulb) segment
of the follicles, as previously reported (Zhou et al., 1995),
whereas K17 is distributed throughout the outer root
sheath and occurs in proximal epidermis as well (refer to
Fig. 7 H). Thus, it would appear that lef-1 protein is not
synthesized in differentiating epithelial cells of embryonic
mouse skin.
Keratin 17 is expressed in several mature epithelia
whose development is known to depend on epithelial–
mesenchymal interactions mediated by lef-1. These in-
clude vibrissae, salivary glands, tooth, and thymus (Fig. 10,
A–D, respectively). To further probe the relationship be-
tween K17 and lef-1 expression, we examined these tissues
in e14.5-d mouse embryos. Again, we detected K17 immu-
noreactivity at an early step in the morphogenesis of these
Figure 9. Colocalization of
K17 and lef-1 during skin de-
velopment. Sections were
prepared from fresh-frozen
mouse embryos at specific de-
velopmental stages and im-
munostained for K17 and for
the transcription factor lef-1,
either on consecutive (A and
B and E and F) or the same
sections (C and D, double im-
munofluorescence). (A and
B) Upper dorsum of a e12.5-d
embryo stained for K17 (A)
and lef-1 (B). Brackets de-
note placodes at various
stages of their formation re-
sulting from epithelio–mesen-
chymal interactions. A
strong, epithelium-restricted
staining for K17 is seen in
these placodes, while the sig-
nal for lef-1 is confined to the
nucleus in both the epithelial
cells and the proximal mesen-
chymal cells. (C and D) Up-
per dorsum of a e12.5-d em-
bryo subjected to double
immunofluorescence for K17
(C) and lef-1 (D). K17 is ex-
pressed strongly in the pla-
code epithelial cells denoted
by an arrow and in the peri-
derm (inverted arrowhead),
and sporadically in the em-
bryonic basal layer. Al-
though excluded from the
periderm, a strong nuclear
staining for lef-1 is detected
in the placode epithelial cells
and in the mesenchymal cells
proximal to it. In addition,
embryonic basal cells that ex-
press K17 strongly are also
immunopositive for lef-1. The
upward arrowheads in A–D
depict the interface between
the epithelium and the under-
lying mesenchyme. (E and F)
Consecutive sections through
vibrissae follicles (v) from an
e14.5-d embryo subjected to
immunofluorescence for K17
(E) and lef-1 (F). Although K17 immunoreactivity is restricted to the epithelial cells, the signal for lef-1 is particularly strong in the nu-
cleus of mesenchymal cells (m) surrounding the epithelium. Arrowheads, interface between the epithelium and the mesenchyme. Bars:
(A and B) 70 mm; (C–F) 20 mm.The Journal of Cell Biology, Volume 143, 1998 480
tissues (Fig. 10, A9–D9). Collectively, these findings estab-
lish that the K17 gene is expressed in a number of develop-
ing tissues whose formation partly depend upon lef-1.
Ectopic Expression of lef-1 Correlates with K17 
Induction in the Epidermis of Adult Transgenic Mice
The intriguing correspondence between the timing and lo-
cation of lef-1 protein synthesis, a transcription factor al-
legedly involved in the regulation of hair-specific keratin
genes, and K17, a component of the pilosebaceous appara-
tus, raises the possibility that the former may contribute to
regulate the latter during early skin morphogenesis. In
support of this possibility, inspection of the 59 upstream se-
quence of the mouse K17 gene reveals the presence, in
three distinct locations, of a nucleotide sequence motif, 59-
CTTTGWW-39, which fits perfectly the consensus DNA
binding site for lef-1 (Powell et al., 1991; Clevers and
Grosscheld, 1996). A perfect consensus binding site for
lef-1 occurs in the third intron of the human K17 gene
(GenBank/EMBL/DDBJ accession number Z19574) (Troy-
anovsky et al., 1992). Such lef-1 consensus binding sites oc-
cur in the 59 upstream regulatory region of all the hair fol-
licle-specific genes examined so far, and can mediate the
transactivation of a reporter gene in a lef-1–dependent
manner in an heterologous expression assay ex vivo (Zhou
et al., 1995). Based on these findings we examined the ex-
pression of K17 in two mouse models in which lef-1 ex-
pression has been genetically manipulated: mice that ec-
topically overexpress lef-1 in epidermis via a keratin 14
gene promoter (Zhou et al., 1995), and mice harboring a
null mutation for lef-1 (van Genderen et al., 1994).
Transgenic mice that express lef-1 under the control of
the K14 gene promoter show the presence of lef-1 in the
basal layer of epidermis, oral mucosa, and a few other
stratified epithelia. These mice feature an abnormal pat-
terning of hair follicles over their trunk, and consistent
with the postulated role for lef-1 in appendageal morpho-
genesis (van Genderen et al., 1994), they show ectopic ap-
pendages in the oral mucosa (Zhou et al., 1995). Paraffin-
embedded skin samples from 11-d-old transgenic pups and
controls were provided by E. Fuchs. The epidermis of
these mice display a normal morphology and distribution
of key markers of terminal differentiation, such as K10
and filaggrin (data not shown) (Zhou et al., 1995). Addi-
tionally, the interfollicular epidermis does not stain posi-
tively for K6 (Fig. 11 B), a marker for abnormal prolifera-
tion that is coregulated with K17 after various acute
challenges to the skin (Takahashi et al., 1997; 1998). Yet,
unlike the situation in control (Fig. 11 A), a significant
fraction of basal cells in interfollicular epidermis express
K17 in lef-1 transgenic tissue (Fig. 11, C and D). The spec-
ificity of this induction and the absence of any other de-
tectable changes in the properties of progenitor basal ke-
ratinocytes in the mature epidermis of [K14 promoter] lef-1
mice supports the possibility that lef-1 may be involved in
aspects of K17 expression at an early stage of appendageal
morphogenesis.
Transgenic mice that harbor a null mutation in the lef-1
gene feature a significantly reduced number of hair folli-
Figure 10. Distribution of
K17 protein in adult- and em-
bryonic-stage epithelia known
to develop in a lef-1–depen-
dent manner. Sections were
prepared from either paraffin-
embedded (A–D) or fresh-
frozen e14.5-d whole embryos
(E–H), and immunostained
for K17 using a peroxidase-
based detection method. A
(adult) and E (embryo), whis-
ker pads; vib, a tangentially
sectioned vibrissae follicle in
A. B (adult) and F (embryo),
submaxillary gland; me, myo-
epithelium that envelops the
glandular epithelial tissue. C
(adult) and G (embryo), tooth.
Arrowhead, enamel organ. D
(adult) and H (embryo), thy-
mus. Bar, 100 mm.McGowan and Coulombe K17 Expression during Skin Morphogenesis 481
cles that are reportedly shorter and delayed in their matu-
ration (van Genderen et al., 1994). We found that the hair
follicle profiles present show positive immunostaining for
K17 in the ORS, however these samples lacked hair shafts
(data not shown). Whether these follicles form as a result
of functional redundancy with other related transcription
factors in lef-1–null mice, or whether lef-1 preferentially
impacts on the formation of a specific type of hair follicle,
remains unclear at present. From this we conclude that lef-1
expression is not essential for the morphogenesis of all
pelage hairs or for the expression of K17 in the ORS.
Discussion
K17 and the Onset of Epithelial Differentiation during 
Skin Development
Essential to understanding the mechanisms that underlie
the developmental choices that occur during mammalian
organogenesis is the identification of the stages at which
commitment to various cell lineages and subsequent dif-
ferentiation occur. The embryonic epidermis represents an
excellent system for such studies as it differentiates and
expands from a single-layered embryonic ectoderm to
form a stratified squamous epithelium. Concomitantly,
cells from within this tissue undergo separate programs of
differentiation to form epidermally derived appendages
like hair, nail, teeth, and glands. The monitoring of epider-
mal and hair-specific keratin gene expression has signifi-
cantly contributed to our current understanding of these
processes (Dale et al., 1985; Kopan and Fuchs, 1989; Greer
and Roop, 1991; Byrne et al., 1994). We surmised that
given their constitutive expression in various appendages
and their rapid induction after acute injury, the nonepider-
mal keratin genes K6 and K17 may provide additional in-
sights into skin development. We found that expression of
K17 is initiated in the undifferentiated ectoderm at the sin-
gle- or two-layer stage, starting in e10.5-d mouse embryos.
Figure 11. Immunolocalization of keratins in the skin of transgenic mice that ectopically express lef-1 in the basal layer of epidermis.
Skin tissue samples were fixed in Bouin’s, paraffin embedded, and then sections were immunostained for either K17 or K6 using a per-
oxidase-based detection method. (A) Trunk skin from a 11-d-old nontransgenic littermate control stained for K17. As in Fig. 5, the hair
follicle (hf) ORS is strongly immunostained, whereas the interfollicular epidermis (epi) is negative. (B–D) Trunk skin from a 11-d-old
transgenic animal stained for K6 (B) and K17 (C and D). Consistent with the normal histology (data not shown), K6 protein occurs in
the innermost layers of the hair follicle ORS, whereas the epidermis is negative. In contrast, the basal layer of transgenic epidermis
shows a strong signal for K17 (arrowheads in C and D), as does the hair follicle ORS. Arrowhead, dermo-epidermal interface. Bar,
100 mm.The Journal of Cell Biology, Volume 143, 1998 482
The spatiotemporal pattern of K6 expression is different,
and coincides with the onset of expression of several dif-
ferentiation-specific markers at a later time (see below).
Our data point to the intriguing possibility that onset of
K17 expression in the embryonic ectoderm reflects a com-
mitment towards distinct epithelial lineages, and prompt
us to propose a revised model for skin development as
shown in Fig. 12.
In this model, the morphogenesis of the major types of
skin epithelia is segmented into four distinct yet logically
interconnected phases, which can be described as follows:
Phase 1. Commitment to Form a Complex Epithelium.
Up to ze9.5 d, the single-layered ectoderm covering the
embryo is undifferentiated and expresses the keratins
characteristic of simple epithelia, K8, and K18 (Jackson et
al., 1981; Thorey et al., 1993). We propose that the onset of
transcription factor AP-2 expression, soon followed by that
of its target genes K5 and K14 (Byrne et al., 1994), reflects
a commitment towards the formation of a complex epithe-
lium. Of note, K5 and K14 (along with variable levels of
K15) are the only keratins that are expressed in all the
complex (soft) epithelia in the adult, where they typically
occur in the least differentiated progenitor cells (Moll et
al., 1982; O’Guin et al., 1990).
Phase 2. Definition of Major Epithelial Lineages.  We pro-
pose that onset of K17 expression in a subpopulation of
the K5–K14- and K8–K18-expressing embryonic ectoder-
mal cells, which occurs in the e10.5 –e12.5-d time window,
signifies a commitment to form a nonepidermal tissue such
as a hair follicle, a gland, or the periderm. This commit-
ment is the result of a set of specific molecular instructions
(e.g., lef-1–mediated epithelio–mesenchymal interactions)
that do not take place in epidermal precursors, which rep-
resents the default pathway (Kopan and Fuchs, 1989). We
have demonstrated that onset of K17 expression may oc-
cur within the single-layer embryonic ectoderm, or in the
lower or upper layer of the two-layer ectoderm (depend-
ing on the region of the embryo), in cells that are mitoti-
cally active (this study; Byrne et al., 1994). These data ex-
tend the work of Byrne and colleagues (1994), who
observed that the initial stratification of the ectoderm does
not correspond to a polarization or differentiation event.
Moreover, our temporal assignment for this phase is in
complete agreement with the results obtained by Sanes
and coworkers (1986), who used retrovirally marked cells
to determine the genealogy of the various cell types in sev-
eral mouse tissues. Their study showed that commitment
to peridermal and follicular cell fates occurs at ze11 d, but
that before this all ectodermal cells maintain pluripotenti-
ality.
Phase 3. Cellular Expansion.  For a period of z48 hours
that extends from the onset of K17 gene expression to that
of differentiation-specific genes, there is a significant in-
crease in epithelial cell number without molecular indices
of terminal differentiation (see below). We propose that
this period corresponds to an expansion of relatively un-
differentiated cell pools within each of the major epithelial
lineages. Obviously, additional studies are required to ex-
amine gene expression during this poorly-defined phase.
Phase 4. Onset of Lineage-specific Epithelial Differentia-
tion.  Several differentiation-related genes are first ex-
pressed starting at e13.5–e15.5 d, such as K1–K10 (this
study; Byrne et al., 1994), filaggrin, and loricrin (Byrne et
al., 1994; Greer and Roop, 1991) in epidermis, and hard
keratin genes (Byrne et al., 1994) as well as K6 (this study)
in hair follicles. In all these instances, expression of the
marker occurs in a subset of cells within the maturing epi-
thelium, reflecting a polarization in the developing tissue.
Consequently, this phase represents the last one in our
model for the morphogenesis of skin epithelia, as it corre-
sponds to the onset of terminal differentiation.
Although the four steps described occur sequentially for
any individual element (e.g., a single hair follicle), it must
Figure 12. A model for early skin morphogenesis. This model re-
lates the induction of K17 expression in developing mouse skin to
other molecular events as described by Byrne et al. (1994). For
the sake of simplicity, this model focuses on the events involving
keratinocytes and ignores the other cell types. Shading, presence
of K17 protein. (Phase 1) The onset of K5–K14 expression in the
single-layer embryonic ectoderm, beginning at ze9.5 d, reflects a
commitment towards the formation of a complex epithelium. In-
duction of K5–K14 occurs concomitant with, but independently
of, stratification to a two-layered epithelium. (Phase 2) The onset
of K17 expression, starting at ze10.5 d, reflects the determina-
tion of the major lineages in skin epithelia. Specifically, we postu-
late that K17 is induced in the subset of K8–K18, K5–K14 ex-
pressing epithelial cells that are responding to the mesenchymal
cues that induce appendage formation, and in cells that will give
rise to periderm. As is the case for K5–K14 approximately a day
earlier, onset of K17 expression may occur in single-layer ecto-
derm or alternatively, in either layer of a two-layer-thick epithe-
lium, depending on the region of the body. (Phase 3) Cell expan-
sion and onset of epithelial polarization. Between e12.5 and e14.5
d, the epithelial sheet thickens considerably and clusters of K17-
expressing epithelial cells extend into the underlying mesen-
chyme at sites of strong lef-1 transcription factor expression.
Consistent with the lack of differentiation-specific gene expres-
sion, we propose that this time window corresponds primarily to
a cell expansion phase. (Phase 4) Onset of cell type-specific dif-
ferentiation. Starting at e14.5 d as previously reported, terminal
differentiation is initiated within the various lineages as mani-
fested through K1–K10 expression in embryonic epidermis and
hair-specific keratin gene expression in hair germs. The periderm
is destined to be lost via shedding beginning at e16.5 d.McGowan and Coulombe K17 Expression during Skin Morphogenesis 483
be realized, as alluded to in the results section, that they
are not synchronized over the entire skin tissue, since de-
velopment proceeds according to spatial and temporal
gradients.
K17 Is a Candidate Target Gene for Regulation by Lef-1
Considerable progress has been made towards identifying
the mechanisms and molecules that mediate the recipro-
cal, inductive interactions between mesenchymal and epi-
thelial tissues that play an integral role in hair follicle mor-
phogenesis. One such molecule is the lymphoid enhancer
factor, lef-1 (van Genderen et al., 1994; Zhou et al., 1995;
Clevers and Grosschedl, 1996). Lef-1 is a transcription fac-
tor capable of bending DNA, a property that is thought to
influence gene transcription by facilitating the association
of other transcription factors (for review see Clevers and
Grosschedl, 1996). Targeted inactivation of the lef-1 gene
produced major alterations in epithelial tissues that share
a dependency upon epithelial–mesenchymal interactions
for proper morphogenesis (van Genderen et al., 1994).
The spatiotemporal pattern of K17 expression during de-
velopment suggest strongly that this keratin gene may be
regulated by signals generated in the context of such epi-
thelio–mesenchymal interactions, possibly lef-1.
We presented several lines of evidence that support this
notion. First, we have shown a temporal and spatial corre-
spondence between K17 and lef-1 protein synthesis in hair
placodes. Second, we have presented data depicting K17
protein synthesis during the formation of other lef-1 target
organs. Third, we provide convincing evidence that K17 is
expressed in precursor matrix epithelial cells and early dif-
ferentiating trichocytes of fully formed hair follicles. These
cells give rise to the structures of the hair, and the pro-
grams of gene expression associated with these include
several hard keratin genes postulated to be directly regu-
lated by lef-1. To our knowledge, K17 represents the first
instance of a keratin gene expressed in both hard and soft
epithelial tissues. Fourth, there are three consensus bind-
ing sites for lef-1 in the mouse K17 gene, and at least one
in the human K17 gene (the full 59 upstream sequence of
this gene is not yet available). These consensus sites are
identical to those found in hair keratin genes (Powell et
al., 1991, 1992), where they have been found to mediate a
direct transactivation (Zhou et al., 1995). Fifth and finally,
we found that K17 protein is synthesized in the epidermal
basal layer of transgenic mice that ectopically express lef-1
under the control of the K14 promoter.
The connection between K17 and lef-1 expression is im-
portant when one considers the delay between the expres-
sion of lef-1, which begins at ze11 d (Zhou et al., 1995;
Kratochwil et al., 1996), and the subsequent induction of
hair keratin genes at ze14.5–15.5 d. The potential rela-
tionship between lef-1 expression and K17 upregulation
could provide a critical molecular link between the expres-
sion of this transcription factor and the actual commitment
to undergo appendageal organogenesis. The location of
binding sites for lef-1 is different in the K17 and the hair-
specific keratin genes (data not shown). This may repre-
sent an important determinant for the manner with which
lef-1, being an architectural transcription factor, impacts
on the expression of these keratin genes during develop-
ment. Studies are in progress to test whether lef-1 can di-
rectly transactivate the K17 gene promoter.
K17, Wound Healing, and Epidermal Development
Together with our previous work (Paladini et al., 1996; Ta-
kahashi et al., 1997, 1998), the studies reported here estab-
lish that K6, K16, and K17 proteins are all induced in epi-
dermis at the proximal edge of the wound within hours
after acute injury to mouse and human skin. The K17 spe-
cific antisera used for this study allows us to modify our
early studies, in that it appears that the induction of K6,
K16, and K17 genes occurs on the same time scale. At
least early on, this induction occurs in suprabasal kerati-
nocytes, i.e., in cells that have already begun to differenti-
ate. Thereafter, expression of K6, K16, and K17 spreads
distally from the cut edge of the wound, is maintained in
keratinocytes that are migrating into the wound site, and
ceases upon the completion of reepithelialization. The sig-
nificance of this phenomenon, and the precise contribu-
tion of K6, K16, and K17, remain to be ascertained.
Schermer and colleagues (1989) proposed the interesting
idea that this induction may reflect a switch to an alterna-
tive, possibly more primitive mode of epithelial differenti-
ation. From previous work we postulated that these ker-
atins, K16 in particular, may contribute to promote the
cytoarchitectural changes that are typical of keratinocyte
activation (Paladini et al., 1997; McGowan et al., 1998). In
this regard, the data we report here have an impact at two
distinct levels. First, the notion that K17 is synthesized in
soft and hard epithelial cells and that this protein is a ma-
jor component of regenerating epithelia is an intriguing
one. We have preliminary data further supporting this
concept that involve studies with the WE6 antigen, which
is wound inducible in the surface epithelium of the newt
and frogs (Estrada et al., 1993) and corresponds to a type I
keratin (Klatt, K., and R. Tassava, personal communica-
tion). We detect WE6 immunoreactivity in the early dif-
ferentiating cells of hard epithelia in the mouse such as
hair, nail, and filiform papillae of the tongue (Coulombe,
P.A., unpublished observations). Additional studies are
required to further explore the notion that K17, and possi-
bly other wound repair-associated keratins, could perform
a key function in both soft and hard epithelia under resting
conditions. Second, our findings argue that the program of
gene expression characteristic of wound-activated adult
keratinocyte (for review see Coulombe, 1997) may bear a
relationship to that executed by epithelial cells at specific
stages of embryonic development, before expression of
true differentiation-specific genes. The existence of such a
molecular relationship between embryonic development
and adult tissue regeneration has already been evidenced
in other tissues, liver in particular (Michapoulos, 1997).
The event that most convincingly links embryonic devel-
opment and wound repair in skin epithelia is the abundant
expression of K17 in developing hair placodes. In this case
as in adult skin wounds, a group of K17-expressing kerati-
nocytes coordinately expands or migrates into a connec-
tive tissue, suggesting that expression of this particular
keratin may be a molecular trait of keratinocytes involvedThe Journal of Cell Biology, Volume 143, 1998 484
in migration or tissue expansion. Additional lines of evi-
dence support this contention. Appendages have long
been known to contribute keratinocytes to the resurfacing
of wound sites in adult skin, especially in cases involving
partial thickness wounds (Clark, 1993), and we find that
K17 expression is upregulated in the ORS of hair follicles
located proximal to the wound site (data not shown).
Moreover, experimental evidence has recently been pro-
vided for a similar phenomenon involving epithelial cells
originating from eccrine sweat glands (Miller et al., 1998).
An exciting possibility is that the cell type involved in this
case would be the myoepithelial cells, which express K17
constitutively (see below).
In terms of keratin gene expression profile, however,
the periderm appears to better mimic the activated kerati-
nocyte of adult skin wounds. In developing skin, indeed,
uniform and abundant co-expression of K6 and K17 oc-
curs only in the periderm. The function of the periderm re-
mains a mystery (Fisher, 1994). Periderm has been sug-
gested to emanate from sites of epithelio–mesenchymal
interactions (M’Boneko and Merker, 1988). The morpho-
logical changes taking place as it emerges (M’Boneko and
Merker, 1988) bear a striking resemblance to activated ke-
ratinocytes at the edge of adult skin wounds (Paladini et
al., 1996). An open question is whether K17 induction in
the periderm is a byproduct of the inductive interactions
that lead to appendage formation or whether it represents
a critical event in the morphogenesis of this poorly under-
stood cell type. The degree to which the molecular rela-
tionship between periderm and the wound-activated adult
skin keratinocyte extends beyond keratin gene expression
deserves further investigation.
Other than hair placodes and periderm, K17 is ex-
pressed transiently but uniformly in the basal layer of em-
bryonic epidermis ze16.5 d. By that time, the developing
epidermis already features a mature character as judged
by various markers of adult epidermis (Fuchs and Byrne,
1994). This aspect of embryonic K17 expression is of sig-
nificance, as it provides further support to the notion that
K17 expression in epidermis is compatible with mitosis
and not a manifestation of advanced differentiation. This
finding raises several questions, however, including the
fate adopted by these embryonic basal cells, and the mech-
anism(s) responsible for spatially restricting the expres-
sion of this gene to the postmitotic layers in adult epider-
mis subjected to injury and other forms of challenge (as
discussed above).
At another level, our findings may have significant im-
plications with regard to a recent study of perfect wound
healing in K8-null embryos (Brock et al., 1996). These
studies concluded, on the basis that reepithelialization is
not altered in K8-null embryos, that keratin IFs are not an
integral part of the fetal wound repair process. We would
assert that one must look beyond the K8–K18 network, as
these filaments may not play a substantial role once the
skin-specific keratins have begun to accumulate. It may be
possible that the keratins already present at e11.5 d, which
at least include K5, K14, and K17, are sufficient to bring
about wound closure. We are currently exploring the
possibility that the wound repair keratins K6, K16, and
K17 may be expressed during reepithelialization of fetal
wounds.
Speculation on the Function of K17
A fundamental question in the field of keratin filament bi-
ology is why there exists so many homologous proteins. By
virtue of its primary sequence, K17 belongs to a subgroup
of type I keratin genes that includes K14 and K16. A com-
parison of their amino acid sequences reveals that individ-
ual substitutions tend to be grouped within defined seg-
ments of these proteins. Thus, the NH2-terminal head
domains of K14 and K16 are clearly more related to one
another than either is to K17. Conversely, homology
within the COOH-terminal tail domain is greatest be-
tween K14 and K16 for the proximal half segment, while
being greatest for K14 and K17 for the distal half segment.
It is unclear how these variations result in functional dif-
ferences between these type I keratins. What is known is
that human K16 can not entirely complement the pheno-
type associate with a K14-null mutation in transgenic mice,
a behavior that we could map to the COOH-terminal 105
amino acids (Paladini, R.D., and P.A. Coulombe, unpub-
lished data).
Our findings point to a dual function for K17 that may
help to explain the phenotype and ultrastructural pathol-
ogy characteristic of pachyonychia congenita and steato-
cystoma multiplex, two clinical disorders that can arise
from missense mutations affecting the primary sequence
of K17 (McLean et al., 1995; Smith et al., 1997). On the
one hand, the occurrence of cytolysis in at least some K17
mutant-expressing epithelia (McLean et al., 1995) is con-
sistent with a structural role akin to that already defined
for other keratin proteins. It is possible that the synthesis
of K17 protein in the hair matrix and lower portions of the
hair shaft impacts the formation of this structure and
would explain the presence of twisted hairs (pili torti) in
PC patients. On the other hand, our description of the de-
velopmental expression of K17, especially during odonto-
genesis and gland formation, may explain the linkage be-
tween K17 mutation the occurrence of developmental
anomalies such as those characterizing the eyebrow, sweat
glands, and teeth (Munro et al., 1994; McLean et al., 1995).
This would render K17 unique among the keratin genes so
far linked to inherited diseases by suggesting a function for
this protein during the morphogenesis of these tissues.
The context and subcellular distribution of a given pro-
tein can also convey hints about its function. Many of the
epithelial cell types expressing K17, whether normal or ac-
tivated, show contractile or motile activity. An example of
this are the myoepithelial cells of glandular tissues, whose
cytoplasm displays arrays of actin and myosin filaments
organized in a sarcomere-like fashion (Raubenheimer,
1987; Redman, 1994). Contraction of these star-shaped
myoepithelial cells, whose long cytoplasmic projections
envelop the lumenal tissue, is thought to supply the force
needed for propelling the glandular contents into the ducts
(Raubenheimer, 1987; Redman, 1994). Interestingly, as
stated for the periderm epithelium above, myoepithelial
cells resemble activated keratinocytes proximal to the
wound edge (Paladini et al., 1996) in many respects. Thus
it would appear K17-expressing epithelial cells often fea-
ture a prominent actin-based molecular machinery. Al-
though this relationship remains to be established, recent
work would suggest that such cross-talk between filamentMcGowan and Coulombe K17 Expression during Skin Morphogenesis 485
networks, as mediated by linker proteins like plectin
(Wiche, 1989) and BPAG (Yang et al., 1996), is not only
possible but essential (Bousquet and Coulombe, 1996).
This raises the possibility that K17 containing intermedi-
ate filament networks possess unique properties that ren-
der them capable of making such connections.
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